Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9

We conducted two lines of genome-editing experiments of mouse hematopoietic stem cells (HSCs) with the clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9). First, to evaluate the genome-editing efficiency in mouse bona fide HSCs, we knocked out in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Ther Methods Clin Dev
Päätekijät: Byambaa, Suvd, Uosaki, Hideki, Ohmori, Tsukasa, Hara, Hiromasa, Endo, Hitoshi, Nureki, Osamu, Hanazono, Yutaka
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Gene & Cell Therapy 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873578/
https://ncbi.nlm.nih.gov/pubmed/33614821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2021.01.001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia